US FDA approves Adaptimmune therapy for a rare type of cancer
The US Food and Drug Administration (FDA) announced that it has approved Adaptimmune, a pioneering treatment for a rare type of soft tissue cancer that usually affects young adults.
BELIEBTE BEITRÄGE
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVEÜBERTRAGUNG